Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- possível exposição ao sarampo
- indivíduos não vacinados/com vacinação incompleta
- febre
- tosse
- coriza
- conjuntivite
- Manchas de Koplik
- exantema maculopapular
Факторы риска
- exposição ao vírus do sarampo
- ausência de imunização anterior contra o sarampo
- falha na resposta vacinal contra o sarampo
Диагностические исследования
Исследования, которые показаны в первую очередь
- sorologia de imunoglobulina M (IgM) e de imunoglobulina G (IgG) específica ao sarampo (ELISA)
- saliva
Исследования, проведение которых нужно рассмотреть
- sorologia das fases aguda e convalescente de IgG específica para sarampo
- detecção de ácido ribonucleico (RNA) do sarampo por reação em cadeia da polimerase
- detecção de antígeno mediante anticorpo fluorescente ou técnicas de reação em cadeia da polimerase
- isolamento do vírus no sistema de cultura de tecido
Алгоритм лечения
Составители
Авторы
Elizabeth Barnett, MD
Professor of Pediatrics
Boston University School of Medicine
Boston Medical Center
Boston
MA
Раскрытие информации
EB receives clinical trial funds from Pfizer (COVID, PCV20, and RSV vaccines) and GSK (MMRV vaccine). She receives royalties from Elsevier (Immigrant Medicine), AAP (Nelson's antimicrobial therapy), and honoraria from AAP (Red Book). She participated in an Advisory Board (Sobi, RSV).
Рецензенты
Sharon Nachman, MD
Professor of Pediatrics
Division Chief Pediatric Infectious Disease
State University of New York at Stony Brook
Stony Brook
NY
Divulgaciones
SN declares that she has no competing interests.
Linda Nield, MD, FAAP
Professor of Pediatrics
West Virginia University School of Medicine
Morgantown
WV
Divulgaciones
LN is an author of a reference cited in this topic.
Aisha Sethi, MD
Assistant Professor of Medicine
Associate Residency Program Director
University of Chicago
Chicago
IL
Divulgaciones
AS declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
McLean HQ, Fiebelkorn AP, Temte JL, et al; Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34.Texto completo Resumen
UK Health Security Agency. Measles: the green book, chapter 21. Dec 2019 [internet publication].Texto completo
Centers for Disease Control and Prevention. Child and adolescent immunization schedule: recommendations for ages 18 years or younger, United States, 2025. Nov 2024 [internet publication].Texto completo
Centers for Disease Control and Prevention. Adult immunization schedule: recommendations for ages 19 years or older, United States, 2025. Nov 2024 [internet publication].Texto completo
Committee on Infectious Diseases, American Academy of Pediatrics. Measles. In: Kimberlin DW, Banerjee R, Barnett ED, et al, eds. Red Book: 2024-2027 Report of the Committee on Infectious Diseases. 33rd ed. Itasca, IL: American Academy of Pediatrics; 2024.Texto completo
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible aquí.
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad